Article Versions Notes

Chiba R, Miyakawa K, Aoki K, Morikawa TJ, Moriizumi Y, Degawa T, Arai Y, Segawa O, Tanaka K, Tajima H, et al. Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection. Biomedicines. 2022; 10(9):2291. https://doi.org/10.3390/biomedicines10092291

Chiba, Ryotaro, Kei Miyakawa, Kotaro Aoki, Takamitsu J. Morikawa, Yoshiki Moriizumi, Takuma Degawa, Yoshiyuki Arai, Osamu Segawa, Kengo Tanaka, Hideji Tajima, and et al. 2022. "Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection" Biomedicines 10, no. 9: 2291. https://doi.org/10.3390/biomedicines10092291

Chiba, R., Miyakawa, K., Aoki, K., Morikawa, T. J., Moriizumi, Y., Degawa, T., Arai, Y., Segawa, O., Tanaka, K., Tajima, H., Arai, S., Yoshinaga, H., Tsukada, R., Tani, A., Fuji, H., Sato, A., Ishii, Y., Tateda, K., Ryo, A., & Yoshimura, T. (2022). Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection. Biomedicines, 10(9), 2291. https://doi.org/10.3390/biomedicines10092291